Semin intervent Radiol 2022; 39(04): 387-393
DOI: 10.1055/s-0042-1757315
Review Article

Agents Used for Nerve Blocks and Neurolysis

Richard Wu
1   Emory University School of Medicine, Atlanta, Georgia
,
Bill S. Majdalany
2   Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Meghan Lilly
2   Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
J. David Prologo
2   Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
,
Nima Kokabi
2   Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia
› Author Affiliations

Abstract

The recognition of pain and the treatments used for it are vital for all practitioners. Many types of pain can be treated in a locoregional fashion, which has significant implications not just for any individual patient but for society as a whole. These treatments are most effective when performed in a minimally invasive, image-guided fashion. Interventional radiologists should play a central role in providing these lifestyle-limiting treatments. This article describes the medications most typically used for spinal and extra-axial treatments in the management of patients in pain.



Publication History

Article published online:
17 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain 2022; 163 (02) e328-e332
  • 2 Smith TJ, Hillner BE. The cost of pain. JAMA Netw Open 2019; 2 (04) e191532
  • 3 Anekar A, Cascella M. WHO Analgesic Ladder. In: StatPearls. StatPearls Publishing; 2022
  • 4 Le Daré B, Gicquel T. Therapeutic applications of ethanol: a review. J Pharm Pharm Sci 2019; 22 (01) 525-535
  • 5 D'Souza RS, Warner NS. Phenol nerve block. In: StatPearls. StatPearls Publishing; 2022
  • 6 Halpern D. Histologic studies in animals after intramuscular neurolysis with phenol. Arch Phys Med Rehabil 1977; 58 (10) 438-443
  • 7 Tariq RA, Mueller M, Green MS. Neuraxial Neurolysis. In: StatPearls. StatPearls Publishing; 2022
  • 8 Jackson TP, Gaeta R. Neurolytic blocks revisited. Curr Pain Headache Rep 2008; 12 (01) 7-13
  • 9 Burchiel KJ, Russell LC. Glycerol neurolysis: neurophysiological effects of topical glycerol application on rat saphenous nerve. J Neurosurg 1985; 63 (05) 784-788
  • 10 Pellizzari R, Rossetto O, Schiavo G, Montecucco C. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond B Biol Sci 1999; 354 (1381): 259-268
  • 11 Kim HJ, Seo K, Yum KW, Oh YS, Yoon TG, Yoon SM. Effects of botulinum toxin type A on the superior cervical ganglia in rabbits. Auton Neurosci 2002; 102 (1-2): 8-12
  • 12 Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003; 43 (Suppl 1): S9-S15
  • 13 Swerdlow M. Intrathecal chlorocresol. A comparison with phenol in the treatment of intractable pain. Anaesthesia 1973; 28 (03) 297-301
  • 14 Swerdlow M. Intrathecal neurolysis. Anaesthesia 1978; 33 (08) 733-740
  • 15 Ben Aziz M, Cascella M. Peripheral Neurolytic Blocks. In: StatPearls. StatPearls Publishing; 2022
  • 16 Concha M, Dagnino J, Cariaga M, Aguilera J, Aparicio R, Guerrero M. Analgesia after thoracotomy: epidural fentanyl/bupivacaine compared with intercostal nerve block plus intravenous morphine. J Cardiothorac Vasc Anesth 2004; 18 (03) 322-326
  • 17 Richardson J, Sabanathan S, Eng J. et al. Continuous intercostal nerve block versus epidural morphine for postthoracotomy analgesia. Ann Thorac Surg 1993; 55 (02) 377-380
  • 18 Mahmoudi K, Rashidi M, Soltani F, Savaie M, Hedayati E, Rashidi P. Comparison of intercostal nerve block with ropivacaine and ropivacaine-dexmedetomidine for postoperative pain control in patients undergoing thoracotomy: a randomized clinical trial. Anesth Pain Med 2021; 11 (06) e118667
  • 19 Doi K, Nikai T, Sakura S, Saito Y. Intercostal nerve block with 5% tetracaine for chronic pain syndromes. J Clin Anesth 2002; 14 (01) 39-41
  • 20 Miller RD, Johnston RR, Hosobuchi Y. Treatment of intercostal neuralgia with 10 per cent ammonium sulfate. J Thorac Cardiovasc Surg 1975; 69 (03) 476-478
  • 21 Bick SKB, Eskandar EN. Surgical treatment of trigeminal neuralgia. Neurosurg Clin N Am 2017; 28 (03) 429-438
  • 22 Chen L, Xu M, Zou Y. Treatment of trigeminal neuralgia with percutaneous glycerol injection into Meckel's cavity: experience in 4012 patients. Cell Biochem Biophys 2010; 58 (02) 85-89
  • 23 Sindou M, Tatli M. [Treatment of trigeminal neuralgia with glycerol injection at the gasserian ganglion]. Neurochirurgie 2009; 55 (02) 211-212
  • 24 Kanpolat Y, Savas A, Bekar A, Berk C. Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery 2001; 48 (03) 524-532 , discussion 532–534
  • 25 Wu CY, Meng FG, Xu SJ, Liu YG, Wang HW. Selective percutaneous radiofrequency thermocoagulation in the treatment of trigeminal neuralgia: report on 1860 cases. Chin Med J (Engl) 2004; 117 (03) 467-470
  • 26 Lu VM, Puffer RC, Everson MC, Gilder HE, Burks SS, Spinner RJ. Treating Morton's neuroma by injection, neurolysis, or neurectomy: a systematic review and meta-analysis of pain and satisfaction outcomes. Acta Neurochir (Wien) 2021; 163 (02) 531-543
  • 27 Choi JY, Hong WH, Kim MJ, Chae SW, Suh JS. Operative treatment options for Morton's neuroma other than neurectomy - a systematic review. Foot Ankle Surg 2022; 28 (04) 450-459
  • 28 Poppler LH, Parikh RP, Bichanich MJ. et al. Surgical interventions for the treatment of painful neuroma: a comparative meta-analysis. Pain 2018; 159 (02) 214-223
  • 29 Klontzas ME, Koltsakis E, Kakkos GA, Karantanas AH. Ultrasound-guided treatment of Morton's neuroma. J Ultrason 2021; 21 (85) e134-e138
  • 30 Fanucci E, Masala S, Fabiano S. et al. Treatment of intermetatarsal Morton's neuroma with alcohol injection under US guide: 10-month follow-up. Eur Radiol 2004; 14 (03) 514-518
  • 31 Hughes RJ, Ali K, Jones H, Kendall S, Connell DA. Treatment of Morton's neuroma with alcohol injection under sonographic guidance: follow-up of 101 cases. AJR Am J Roentgenol 2007; 188 (06) 1535-1539
  • 32 Perini L, Perini C, Tagliapietra M. et al. Percutaneous alcohol injection under sonographic guidance in Morton's neuroma: follow-up in 220 treated lesions. Radiol Med (Torino) 2016; 121 (07) 597-604
  • 33 Pabinger C, Malaj I, Lothaller H, Samaila E, Magnan B. Improved injection technique of ethanol for Morton's neuroma. Foot Ankle Int 2020; 41 (05) 590-595
  • 34 Pasquali C, Vulcano E, Novario R, Varotto D, Montoli C, Volpe A. Ultrasound-guided alcohol injection for Morton's neuroma. Foot Ankle Int 2015; 36 (01) 55-59
  • 35 O'Connell NE, Wand BM, Gibson W, Carr DB, Birklein F, Stanton TR. Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev 2016; 7 (07) CD004598
  • 36 Wie C, Gupta R, Maloney J, Pew S, Freeman J, Strand N. Interventional modalities to treat complex regional pain syndrome. Curr Pain Headache Rep 2021; 25 (02) 10
  • 37 Imani F, Hemati K, Rahimzadeh P, Kazemi MR, Hejazian K. Effectiveness of stellate ganglion block under fluoroscopy or ultrasound guidance in upper extremity CRPS. J Clin Diagn Res 2016; 10 (01) UC09-UC12
  • 38 Makharita MY, Amr YM, El-Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician 2012; 15 (06) 467-474
  • 39 Aggarwal A, Suresh V, Gupta B, Sonthalia S. Post-herpetic neuralgia: a systematic review of current interventional pain management strategies. J Cutan Aesthet Surg 2020; 13 (04) 265-274
  • 40 Hayase J, Patel J, Narayan SM, Krummen DE. Percutaneous stellate ganglion block suppressing VT and VF in a patient refractory to VT ablation. J Cardiovasc Electrophysiol 2013; 24 (08) 926-928
  • 41 Guirguis M, Abdelmalak J, Jusino E, Hansen MR, Girgis GE. Stellate ganglion block for the treatment of hot flashes in patients with breast cancer: a literature review. Ochsner J 2015; 15 (02) 162-169
  • 42 Guttuso Jr T. Stellate ganglion block for treating hot flashes: a viable treatment option or sham procedure?. Maturitas 2013; 76 (03) 221-224
  • 43 Lipov E, Ritchie EC. A review of the use of stellate ganglion block in the treatment of PTSD. Curr Psychiatry Rep 2015; 17 (08) 599
  • 44 Mehrotra M, Reddy V, Singh P. Neuroanatomy, Stellate Ganglion. StatPearls. (Published online 2022). http://www.ncbi.nlm.nih.gov/pubmed/30969629
  • 45 Gunduz OH, Kenis-Coskun O. Ganglion blocks as a treatment of pain: current perspectives. J Pain Res 2017; 10: 2815-2826
  • 46 Fudim M, Boortz-Marx R, Ganesh A. et al. Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2017; 28 (12) 1460-1467
  • 47 Narziev B, Yakubov A, Hamraev R, Salaev O, Tursunov S, Gaffarov S. A case of successful percutaneous ethanol stellate ganglion block on ventricular tachycardia storm. J Cardiol Cases 2020; 23 (05) 234-237
  • 48 Lee MH, Kim KY, Song JH. et al. Minimal volume of local anesthetic required for an ultrasound-guided SGB. Pain Med 2012; 13 (11) 1381-1388
  • 49 Jung G, Kim BS, Shin KB, Park KB, Kim SY, Song SO. The optimal volume of 0.2% ropivacaine required for an ultrasound-guided stellate ganglion block. Korean J Anesthesiol 2011; 60 (03) 179-184
  • 50 Ackerman WE, Zhang JM. Efficacy of stellate ganglion blockade for the management of type 1 complex regional pain syndrome. South Med J 2006; 99 (10) 1084-1088
  • 51 Nascimento MSA, Klamt JG, Prado WA. Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I. Braz J Med Biol Res 2010; 43 (12) 1239-1244
  • 52 Yoo SD, Jung SS, Kim HS. et al. Efficacy of ultrasonography guided stellate ganglion blockade in the stroke patients with complex regional pain syndrome. Ann Rehabil Med 2012; 36 (05) 633-639
  • 53 Robbins MS, Robertson CE, Kaplan E. et al. The sphenopalatine ganglion: anatomy, pathophysiology, and therapeutic targeting in headache. Headache 2016; 56 (02) 240-258
  • 54 Ho KWD, Przkora R, Kumar S. Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review. J Headache Pain 2017; 18 (01) 118
  • 55 Skulpoonkitti B, Day M. Sphenopalatine ganglion blocks. Essentials Interv Tech Manag Chronic Pain. (Published online 2018:519–529). DOI: 10.1007/978-3-319-60361-2_33
  • 56 Kastler A, Cadel G, Comte A. et al. Alcohol percutaneous neurolysis of the sphenopalatine ganglion in the management of refractory cranio-facial pain. Neuroradiology 2014; 56 (07) 589-596
  • 57 Devoghel JC. Cluster headache and sphenopalatine block. Acta Anaesthesiol Belg 1981; 32 (01) 101-107
  • 58 Varghese BT, Koshy RC. Endoscopic transnasal neurolytic sphenopalatine ganglion block for head and neck cancer pain. J Laryngol Otol 2001; 115 (05) 385-387
  • 59 Varghese BT, Koshy RC, Sebastian P, Joseph E. Combined sphenopalatine ganglion and mandibular nerve, neurolytic block for pain due to advanced head and neck cancer. Palliat Med 2002; 16 (05) 447-448
  • 60 Dolan RD, Bazarbashi AN, Nelson E, Chan WW, Ryou M. Lower EUS-guided ganglion impar blockade. VideoGIE 2021; 6 (09) 427-430
  • 61 Scott-Warren JT, Hill V, Rajasekaran A. Ganglion impar blockade: a review. Curr Pain Headache Rep 2013; 17 (01) 306
  • 62 Lim SJ, Park HJ, Lee SH, Moon DE. Ganglion impar block with botulinum toxin type A for chronic perineal pain - a case report. Korean J Pain 2010; 23 (01) 65-69
  • 63 Loev MA, Varklet VL, Wilsey BL, Ferrante FM. Cryoablation: a novel approach to neurolysis of the ganglion impar. Anesthesiology 1998; 88 (05) 1391-1393
  • 64 Reig E, Abejón D, del Pozo C, Insausti J, Contreras R. Thermocoagulation of the ganglion impar or ganglion of Walther: description of a modified approach. Preliminary results in chronic, nononcological pain. Pain Pract 2005; 5 (02) 103-110
  • 65 Usmani H, Dureja GP, Andleeb R, Tauheed N, Asif N. Conventional radiofrequency thermocoagulation vs pulsed radiofrequency neuromodulation of ganglion impar in chronic perineal pain of nononcological origin. Pain Med 2018; 19 (12) 2348-2356
  • 66 Sencan S, Edipoglu IS, Ulku Demir FG, Yolcu G, Gunduz OH. Are steroids required in the treatment of ganglion impar blockade in chronic coccydynia? A prospective double-blinded clinical trial. Korean J Pain 2019; 32 (04) 301-306
  • 67 Zechlinski JJ, Hieb RA. Lumbar sympathetic neurolysis: How to and when to use?. Tech Vasc Interv Radiol 2016; 19 (02) 163-168
  • 68 Yoo Y, Lee CS, Kim J, Jo D, Moon JY. Botulinum toxin type A for lumbar sympathetic ganglion block in complex regional pain syndrome: a randomized trial. Anesthesiology 2022; 136 (02) 314-325
  • 69 Manjunath PS, Jayalakshmi TS, Dureja GP, Prevost AT. Management of lower limb complex regional pain syndrome type 1: an evaluation of percutaneous radiofrequency thermal lumbar sympathectomy versus phenol lumbar sympathetic neurolysis – a pilot study. Anesth Analg 2008; 106 (02) 647-649
  • 70 Liu M, Ni H, Tao J, Xie K. Lumbar sympathetic nerve modulation using absolute ethanol for the treatment of primary lower-extremity hyperhidrosis: a dose-effect pilot study. Med Sci Monit 2021; 27: e928209
  • 71 Brock M, Frangakis C, Georgiades CS. CT-guided, percutaneous ethanol sympatholysis for primary hyperhidrosis. Cardiovasc Intervent Radiol 2018; 41 (03) 477-482
  • 72 Haynsworth Jr RF, Noe CE. Percutaneous lumbar sympathectomy: a comparison of radiofrequency denervation versus phenol neurolysis. Anesthesiology 1991; 74 (03) 459-463
  • 73 Alexander JP. Chemical lumbar sympathectomy in patients with severe lower limb ischaemia. Ulster Med J 1994; 63 (02) 137-143
  • 74 Cross FW, Cotton LT. Chemical lumbar sympathectomy for ischemic rest pain. A randomized, prospective controlled clinical trial. Am J Surg 1985; 150 (03) 341-345
  • 75 Mashiah A, Soroker D, Pasik S, Mashiah T. Phenol lumbar sympathetic block in diabetic lower limb ischemia. J Cardiovasc Risk 1995; 2 (05) 467-469
  • 76 Manchikanti L, Boswell MV, Singh V, Pampati V, Damron KS, Beyer CD. Prevalence of facet joint pain in chronic spinal pain of cervical, thoracic, and lumbar regions. BMC Musculoskelet Disord 2004; 5: 15
  • 77 Manchikanti L, Singh V, Pampati V. et al. Evaluation of the relative contributions of various structures in chronic low back pain. Pain Physician 2001; 4 (04) 308-316
  • 78 Won H-S, Yang M, Kim Y-D. Facet joint injections for management of low back pain: a clinically focused review. Anesth Pain Med 2020; 15 (01) 8-18
  • 79 Manchikanti L, Pampati V, Bakhit CE. et al. Effectiveness of lumbar facet joint nerve blocks in chronic low back pain: a randomized clinical trial. Pain Physician 2001; 4 (01) 101-117
  • 80 Manchikanti L, Damron K, Cash K, Manchukonda R, Pampati V. Therapeutic cervical medial branch blocks in managing chronic neck pain: a preliminary report of a randomized, double-blind, controlled trial: clinical trial NCT0033272. Pain Physician 2006; 9 (04) 333-346
  • 81 Simopoulos TT, Manchikanti L, Singh V. et al. A systematic evaluation of prevalence and diagnostic accuracy of sacroiliac joint interventions. Pain Physician 2012; 15 (03) E305-E344
  • 82 Tong YCI, Yong RJ. Sacroiliac joint injection. Pain Med An Essent Rev. (Published online 2017:241–243). DOI: 10.1007/978-3-319-43133-8_67
  • 83 Rupert MP, Lee M, Manchikanti L, Datta S, Cohen SP. Evaluation of sacroiliac joint interventions: a systematic appraisal of the literature. Pain Physician 2009; 12 (02) 399-418
  • 84 Scholten PM, Patel SI, Christos PJ, Singh JR. Short-term efficacy of sacroiliac joint corticosteroid injection based on arthrographic contrast patterns. PM R 2015; 7 (04) 385-391
  • 85 Bresnahan JJ, Ng AT. Review of sacroiliac joint injection techniques. Curr Pain Headache Rep 2022; 26 (05) 385-390
  • 86 Anderberg L, Säveland H, Annertz M. Distribution patterns of transforaminal injections in the cervical spine evaluated by multi-slice computed tomography. Eur Spine J 2006; 15 (10) 1465-1471
  • 87 House LML, Barrette K, Mattie R, McCormick ZL. Cervical epidural steroid injection: techniques and evidence. Phys Med Rehabil Clin N Am 2018; 29 (01) 1-17
  • 88 Rathmell JP, Benzon HT, Dreyfuss P. et al. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology 2015; 122 (05) 974-984
  • 89 Van Boxem K, Rijsdijk M, Hans G. et al. Recommended dexamethasone dose for epidural administration: response to the comments of Koetsier. Pain Pract 2019; 19 (03) 345-346
  • 90 Vydra D, McCormick Z, Clements N, Nagpal A, Julia J, Cushman D. Current trends in steroid dose choice and frequency of administration of epidural steroid injections: a survey study. PM R 2020; 12 (01) 49-54
  • 91 Kozlov N, Benzon HT, Malik K. Epidural steroid injections: update on efficacy, safety, and newer medications for injection. Minerva Anestesiol 2015; 81 (08) 901-909
  • 92 Lutz GE, Vad VB, Wisneski RJ. Fluoroscopic transforaminal lumbar epidural steroids: an outcome study. Arch Phys Med Rehabil 1998; 79 (11) 1362-1366
  • 93 Oliveira CB, Maher CG, Ferreira ML. et al. Epidural corticosteroid injections for lumbosacral radicular pain. Cochrane Database Syst Rev 2020; 4 (04) CD013577
  • 94 van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016; 51 (06) 1070-1090.e9
  • 95 Candido K, Stevens RA. Intrathecal neurolytic blocks for the relief of cancer pain. Baillieres Best Pract Res Clin Anaesthesiol 2003; 17 (03) 407-428
  • 96 Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995; 80 (02) 290-295
  • 97 Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med 2013; 14 (08) 1140-1163
  • 98 Asif AA, Walayat SK, Bechtold ML, Revanur V, Puli SR. EUS-guided celiac plexus neurolysis for pain in pancreatic cancer patients - a meta-analysis and systematic review. J Community Hosp Intern Med Perspect 2021; 11 (04) 536-542
  • 99 Cope DK, Zhao Z. Interventional management for cancer pain. Curr Pain Headache Rep 2011; 15 (04) 237-243
  • 100 Markman JD, Philip A. Interventional approaches to pain management. Med Clin North Am 2007; 91 (02) 271-286
  • 101 Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics 2011; 31 (06) 1599-1621
  • 102 Vig S, Bhan S, Bhatnagar S. Celiac plexus block – an old technique with new developments. Pain Physician 2021; 24 (05) 379-398
  • 103 Erdine S. Celiac ganglion block. Agri 2005; 17 (01) 14-22
  • 104 Wang PJ, Shang MY, Qian Z, Shao CW, Wang JH, Zhao XH. CT-guided percutaneous neurolytic celiac plexus block technique. Abdom Imaging 2006; 31 (06) 710-718
  • 105 Behbahani K, Chary A, Patel S, Mitchell JW, Fleishon H, Prologo JD. Percutaneous CT-guided cryoablation of the celiac plexus: a retrospective cohort comparison with ethanol. J Vasc Interv Radiol 2020; 31 (08) 1216-1220
  • 106 Niu L, Wang Y, Yao F. et al. Alleviating visceral cancer pain in patients with pancreatic cancer using cryoablation and celiac plexus block. Cryobiology 2013; 66 (02) 105-111
  • 107 Urits I, Schwartz R, Herman J. et al. A comprehensive update of the superior hypogastric block for the management of chronic pelvic pain. Curr Pain Headache Rep 2021; 25 (03) 13
  • 108 Koyyalagunta D, Engle MP, Yu J, Feng L, Novy DM. The effectiveness of alcohol versus phenol based splanchnic nerve neurolysis for the treatment of intra-abdominal cancer pain. Pain Physician 2016; 19 (04) 281-292
  • 109 Hou S, Novy D, Felice F, Koyyalagunta D. Efficacy of superior hypogastric plexus neurolysis for the treatment of cancer-related pelvic pain. Pain Med 2020; 21 (06) 1255-1262
  • 110 Chan P, Garcia-Reyes K, Cronan J. et al. Managing postembolization syndrome-related pain after uterine fibroid embolization. Semin Intervent Radiol 2021; 38 (03) 382-387
  • 111 Park PJ, Kokabi N, Nadendla P, Lindsey T, Dariushnia SR. Efficacy of intraprocedural superior hypogastric nerve block in reduction of postuterine artery embolization narcotic analgesia use. Can Assoc Radiol J 2020; 71 (01) 75-80